Closed Loop Medicine

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Teva UK and Closed Loop Medicine Announce Strategic Partnership to Advance Development of Personalised Medicines

Details:

Under the agreement, Teva will use Closed Loop Medicine’s proprietary SaMD platform which advances the development of personalised medicines, including CLM-HT01 (amlodipine), in patients with chronic disorders by combining dose-optimised drug therapy with digital care.

Lead Product(s): Amlodipine

Therapeutic Area: Cardiology/Vascular Diseases Product Name: CLM-HT01

Highest Development Status: UndisclosedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Teva Pharmaceutical Industries

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership March 26, 2024

ASK
US

Upload
your Marketing & Sales content

Closed Loop Medicine

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Closed Loop Medicine and Pharmanovia Enter a Co-Development Partnership for Precision Medicine Combination Therapeutics

Details:

Under the partnership, Closed Loop’s proprietary Software-as-a-Medical Device dosing optimization technology will be combined with Pharmanovia’s established anti-hypertensive medicines to develop drug + software product solutions for the treatment of hypertension.

Lead Product(s): Undisclosed

Therapeutic Area: Cardiology/Vascular Diseases Product Name: Undisclosed

Highest Development Status: PreclinicalProduct Type: Undisclosed

Partner/Sponsor/Collaborator: Pharmanovia

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership May 17, 2023

ASK
US

Upload
your Marketing & Sales content